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Abstract
Obstructive sleep apnea (OSA) is a potential independent risk fac-
tor for postoperative complications, adverse surgical outcomes, and 
longer hospital stays. Obese patients with OSA have increased post-
operative complications. An estimated 25-30% of pre-operative pa-
tients are at a high risk for OSA. A novel, non-invasive respiratory 
volume monitor (RVM) has been developed to provide a real time 
respiratory curve demonstrating lung volumes as well as a continu-
ous, display of minute ventilation, tidal volume and respiratory rate. 
Clinical application of this device in the post-anesthesia care unit 
(PACU) can “unmask” post-operative apneic events resulting from 
partial or complete airway collapse due to the residual effects of 
narcotic administration and volatile and/or intravenous anesthetics. 
Clinical examples from two patients, one with known OSA and one 
without a previous diagnosis of OSA, monitored in the PACU with 
RVM are presented here. Post-operatively both patients had an in-
crease in apneic episodes with significant decreases in their MV 
during apneic episodes after opioid administration as compared to 
pre-op baseline. In addition, oxygen saturation, for both patients, 
which is an essential component of current respiratory monitor-
ing remained normal in the cases presented, despite the significant 
decreases in MV. Continuous RVM monitoring demonstrates both 
changes in respiratory patterns and overall adequacy of ventilation, 
and allows practitioners to quantify the increase in the number and 
duration apneic episodes as a response to narcotic administration. 
These case studies demonstrate that a non-invasive respiratory vol-
ume monitoring system can detect and quantify respiratory distur-
bances that currently go undetected.
Keyword: Non-invasive; Respiratory; Volume; Monitor; Apnea; 
Ventilation; Post-operative; Quantitative
Introduction
Previous studies have established obstructive sleep apnea 
(OSA) as an independent risk factor for postoperative com-
plications, adverse outcomes, and longer hospital stays [1-
3]. Patients with OSA have an increase in post-operative 
complications, such as: oxygen desaturation, atelectasis, and 
increased pain [4]. OSA remains underdiagnosed with an es-
timated 25-30% of pre-operative patients at a high risk for 
OSA [5].The standard measure of OSA is the apnea-hypop-
nea index (AHI): the number of apneas and hypopneas per 
hour of sleep [6]. The sleep monitoring equipment required 
to calculate AHI is not generally available outside of the 
laboratory setting. Standard polysomnography (PSG) data 
acquired in the sleep laboratory does not assess the effects 
of opioids or supplemental oxygen, which can dramatically 
alter respiratory physiology and are commonly used in the 
post-operative setting. Therefore it is not readily translatable 
to the postoperative setting where oxygen therapy and the 
use of opioids for pain management are ubiquitous. Further, 
the AHI is mostly suitable for post-hoc analysis, rather than 
real-time, actionable, clinical, point-of-care decision-mak-
ing. These deficiencies are the likely cause of the lack of 
correlation between pre-operative OSA severity and post-op-
erative respiratory compromise that has been demonstrated 
in several studies [7-11]. OSA events may be more frequent 
or severe post-operatively than demonstrated in the sleep 
laboratory [2, 7-11]. These “unmasked” post-operative ap-
neic events can result from partial airway collapse due to the 
residual effects of narcotic administration and volatile and/
or intravenous anesthetics [12, 13], making adequate respi-
ratory monitoring in the post-anesthesia care unit (PACU) 
even more essential.
In the PACU, conventional respiratory monitoring and 
subjective clinical assessment lack the ability to detect and 
quantify apneas in real-time, and as a result, patients may 
Manuscript accepted for publication January 8, 2014
aDepartment of Anesthesiology, Perioperative and Pain Medicine, 
 Brigham and Women’s Hospital, Harvard Medical School, Boston, 
 MA, USA
bSchool of Nursing, West Virginia University, Morgantown WV, USA
cRespiratory Motion, Inc., Waltham MA, USA
dDepartment on Anesthesia, Massachusetts General Hospital, Harvard 
 Medical School, Boston, MA, USA
eCorresponding author: Diane Ladd, 411 Waverley Oaks Rd, USA. 
 Email: dladd@respiratorymotion.com
doi: http://dx.doi.org/10.14740/jocmr1718w
   209                                     210
J Clin Med Res. 2014;6(3):209-214Voscopoulos et al
Articles © The authors   |   Journal compilation © J Clin Med Res and Elmer Press Inc™   |   www.jocmr.org
go untreated. Oxygen desaturation, which can result from 
prolonged or frequent apnea, may be masked by the use of 
supplemental oxygen; clinical observation data are intermit-
tent and subjective, and capnography has challenges with 
implementation and consistency of use. Until recently, there 
has been no continuous, non-invasive, objective method for 
measuring disturbances in breathing patterns in non-intubat-
ed patients and quantify the adequacy of ventilation. This has 
complicated attempts to determine the full scope of post-op-
erative airway obstruction. A non-invasive respiratory vol-
ume monitor (RVM) (ExSpiron, Respiratory Motion, Inc.) 
has been developed to provide a real time respiratory volume 
curves accompanied by a continuous, display of minute ven-
tilation (MV), tidal volume (TV) and respiratory rate (RR). 
This FDA approved impedance based RVM system has been 
demonstrated to provide accurate measurements of MV, TV 
and RR in non-intubated patients [14, 15]. Previous work 
has shown that opioid use in patients with MV less than 80% 
predicted values could lead to marked decrease to levels be-
low 40% predicted [16, 17]. The RVM curve can show re-
spiratory patterns and real-time decreases in MV that can be 
used as a proxy for apneic breathing patterns.
Two cases are reported here, showing RVM use in the 
PACU. One patient had a pre-operative diagnosis of OSA 
and the other one did not. Permission was obtained from 
both patients for publication.
Case Reports
In the following cases MV, TV and RR measurements were 
derived from continuous respiratory volume curves (30 sec-
ond averages updating every 5 seconds). Apneic events were 
defined as episodes with no detected breaths lasting at least 
10 seconds, and hypopneic events were defined as episodes 
lasting at least 10 seconds with a tidal volume reduction of 
at least 50% from baseline. MV, TV, and RR were calculated 
during apneic and non-apneic periods. A respiratory distur-
bance index (RDI) was also calculated and defined as the 
number of apneic and hypopneic episodes per hour.
Case 1
Patient A: 79-year-old male, 100 kg, 168 cm (BMI = 35kg/
m2) underwent knee replacement surgery under regional an-
esthesia. Past medical history was positive for OSA, asth-
ma, and chronic obstructive pulmonary disease. Prior to the 
procedure, the patient received a single injection femoral 
nerve block and spinal anesthesia. Pre-operatively, 50 μg of 
fentanyl and 1 mg of midazolam were administered intrave-
Figure 1. Example traces from patient A. a)Timeline of patient’s stay in the post-anesthesia care unit (PACU), with each apnea/
hypopnea plotted; b) 30 Second trace of normal breathing pattern (minute ventilation (MV] = 14.2 L/min, RR = 11, tidal volume (TV) 
= 1.3 L); c) 30 second trace from an apneic time period (MV = 2.4 L/min, respiratory rate (RR) = 2, TV = 1.2 L); d) 120 second trace 
from a period with repetitive apneas. (MV = 5.9 L/min, RR = 6, TV = 0.99 L).
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nously and the patient received an additional 15 μg fentanyl, 
262 mg propofol, and 2 mg midazolam intra-operatively. He 
received no additional opioids during his PACU stay. RVM 
data were collected for a total of 292 minutes (22 minutes 
pre-operatively, 132 minutes during surgery, and 138 min-
utes during recovery in the PACU). Vital sign measurements 
and pulse oximetry data were also obtained. Supplemental 
oxygen was supplied (2 L/min via nasal cannula) during the 
PACU stay.
Using a standard formula based on body surface area 
(BSA) for males (BSA × 4), patient A’s predicted MV (suf-
ficient to maintain blood oxygen and carbon dioxide levels 
under baseline conditions) was calculated to be 8.3 L/min. 
His measured MV, recorded by the RVM prior to surgery 
during quiet breathing, was 15.1 ± 0.6 L/min (mean ± SEM), 
likely due to anxiety during the pre-operative period. He 
had 3 episodes of hypopnea noted in the 22 minutes of pre-
operative RVM recordings after the administration of 1 mg 
of midazolam prior to his femoral block. Post-operatively, 
he had 29 apneic and hypopneic events, averaging 17 ± 4.9 
sec in length during his PACU stay (Fig. 1a). During one 
episode of depressed breathing, his MV decreased to 2.4 L/
min, equivalent to 29% of his predicted MV and 16% of his 
pre-operative MV (Fig. 1c). Although recovery breaths fol-
lowing apneic episodes were on the order of 1L (Fig. 1d), 
they did not sufficiently restore MV to baseline levels (MV = 
5.9 L/min, 40% of pre-op baseline). The apneic events were 
concentrated over a period of 78 minutes (RDI = 22 events/
hour) during the time that the patient was observed to be 
dozing on and off.
Pre-operatively and post-operatively, the RVM mea-
sured a natural variation in his MV. A systematic post-hoc 
analysis found that pre-operatively MV ranged from 7.2 to 
23.8 L/min with an average of 15.1 L/min and 100% of all 
readings were above 80% of this patient’s predicted MV 
(6.6 L/min) (Fig. 2a). Post-operatively, the distribution of 
MV measurements was drastically shifted. While the aver-
age MV (13.8 L/min) remained above predicted (8.3 L/min), 
the range of recorded MV was from a dangerously low level 
of 0.4 L/min during periods of apneic episodes to 28.0 L/
min. A histogram, showing the relative distribution of mea-
sured MV both pre-operatively (black) and post-operatively 
(blue), is shown in Figure 2a, left. The systematic change in 
MV is better visualized as a shift in the cumulative distribu-
tion function (CDF) of MV values from the pre-operative 
(Pre-op) to post-operative (Post-op) periods (Fig. 2a) (right). 
These CDFs plot the fraction of time when his MV was less 
than or equal to a particular MV measurement. Pre-opera-
tively, 100% of MV measurements were greater than 80% 
predicted. Post-operatively, 10% of the patient’s MV was 
Figure 2. (a, b) Distribution of minute ventilation (MV) in both patients. Histograms (left panels) show the fraction of MV measurements 
at a particular MV level prior to surgery (black) and after surgery (blue - before opioid and red - after opioid). The cumulative distribu-
tions (right panels) show the fraction of measurements below a given MV level during a given period of time (black - pre-op, blue - post-
op pre-opioid, and red - post-op post-opioid). In patient A (top panels), average MV drops from 15.1 to 13.8 L/min and 10% of the time 
post-operatively the patient’s MV is below 80% predicted, in the “at risk” zone (yellow). In patient B (bottom panels), the average MV 
drops from 8.4 L/min pre-operatively to 7.4 L/minpost-operatively (blue) and further drops to 6.3 L/min after the administration of the 
opioid (red). Post-opioid, patient B spendsnearly 13% of the time with MV below 40% of predicted in the “unsafe” zone (red).
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below 80% predicted (“at risk” zone) and 1% of the time it 
was below 40% predicted (“unsafe” zone). Pulse oximetry 
data were recorded during the PACU stay and the oxygen 
saturation never fell below 95%, he received oxygen (2 L via 
nasal cannula); there was no indication of apneic breathing.
Case 2
Patient B: 73-year-old male, 94 kg, 183 cm (BMI = 28 kg/
m2) underwent knee replacement surgery under regional an-
esthesia. Past medical history was negative for OSA, or any 
other chronic respiratory conditions. Before the procedure, 
the patient received a single injection femoral nerve block 
and spinal anesthesia. Pre-operatively, 50 μg of fentanyl and 
1 mg midazolam were administered intravenously. Intra-
operatively, the patient received intravenously an additional 
125 μg fentanyl, 135 mg propofol, and 1.5 mg midazolam. 
RVM data were collected for 558 minutes (111 minutes 
pre-op, 115 minutes during surgery, and 332 minutes in the 
PACU). Vital sign and oxygen saturation measurements 
were also obtained. The patient entered the PACU on 6 L/
min of O2 via face mask but was switched to room air after 
15 minutes. One hundred and seventy five minutes after ar-
rival in the PACU, the patient received 2 mg of morphine 
intravenously.
Based on the BSA formula, his predicted MV was 8.7 L/
min, consistent with his MV measured prior to surgery (8.4 
± 0.2 L/min, mean ± SEM). He had no episodes of apnea 
noted in the 111 minutes of RVM recording before surgery. 
Post-operatively, he had 88 apneic events occurring over 5.5 
hours in the PACU (RDI = 16 events/hour). He had two dis-
tinct time periods where repetitive apneas occurred: one pri-
or to the administration of 2 mg morphine and one after the 
morphine was administered (Fig. 3a). During apneic breath-
ing episodes his MV was reduced to 4.5 L/min, 54% of his 
pre-operative MV (Fig. 3c). Similar to patient A, recovery 
breaths were not large enough to compensate for the apnea 
and return MV to baseline levels (Fig. 3d) (MV = 4.7 L/min, 
56% of pre-op). Prior to opioid dosing, 18 apneic events oc-
cur over 1.5 hours (RDI = 12 events/hour) with an average 
length of 14 ± 4 sec. After administration of a single small 
dose of opioid, the apneic events became more frequent and 
longer in duration and snoring was observed. Seventy events 
occurred in the 1.4 hours post-opioid (RDI = 50 events/hour) 
with an average apnea length of 18 ± 5 seconds.
Similar to patient A, the pre-operative RVM measured 
MV ranged from 2.6 to 17.7 L/min with an average of 8.4 
L/min (Fig. 2b) (left). Over 70% of pre-operative MV mea-
surements were above 80% and 98% were above 40% of this 
patient’s predicted MV (Fig. 2b) (right). Post-operatively, 
the average MV was decreased from preoperative levels 
to7.4 L/min before the opioid was given and dropped further 
to an average of 6.3 L/min after the opioid was given, where 
MV fell to as low as 1.0 L/min during periods containing 
apneic episodes. Postoperatively in the 175 minutes before 
the opioid was given in the PACU, 51% of the time patient 
B’s MV was below 80% predicted and 4% of the time below 
40% predicted MV. In the 157 minutes after opioid adminis-
tration prior to leaving the PACU, 63% of the time his MV 
was below 80% predicted and 13% of the time was below 
Figure 3. Example traces from patient B. a) Timeline of patient’s stay in the post-anesthesia care unit (PACU), with each ap-
nea/hypopnea plotted; b) 30 Second trace of normal breathing pattern before opioid administration (minute ventilation (MV) 
= 8.2 L/min, RR = 11, TV = 730 m); c) 30 second trace from an apneic time period after opioid administration (MV = 4.5 L/min, 
RR = 6, TV = 750 mL); d) 120 second trace from a period with repetitive apneas. (MV = 4.7 L/min, RR = 6.5, TV = 730 mL).
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40% predicted. Thirteen percent of the time his MV was be-
low 40% of predicted, post-opioid, compared to 4% of the 
time pre-opioid and less than 2% of the time pre-operatively. 
The cumulative distribution of MV values for patient B dur-
ing pre-op, post-op pre-opioid and post-op post-opioid peri-
ods are shown in Figure 2b, right. Pulse oximetry data were 
recorded during the PACU stay, but the oxygen saturation 
never fell below 95% and there were no indications that ap-
neic breathing had occurred.
Discussion
  
Improvements in respiratory monitoring in the PACU could 
enable clinical staff to accurately assess respiratory status, 
promoting timely interventions to address potential respi-
ratory compromise. These case studies demonstrate how a 
non-invasive respiratory volume monitoring system can de-
tect and quantify respiratory disturbances that currently go 
undetected. RVM provides both a real-time respiratory vol-
ume trace that displays both changes in respiratory pattern 
and episodes of true apnea, as well as a quantitative display 
of minute ventilation, an important metric of respiratory 
competence.
Oxygen saturation, which is an essential component of 
current respiratory monitoring, remained normal in the cas-
es presented, despite noted decreases of MV down to less 
than 5% predicted (0.4 L/min) during apneic periods. This 
finding reinforces the fact that a decrease in measured oxy-
gen saturation, especially in the presence of supplemental 
oxygen, is an insensitive indicator of respiratory status. Re-
duction in oxygen saturation occurs cyclically with apneic 
breathing and can easily be missed by current monitoring 
systems or be masked by oxygen administration. The RVM 
was not only able to measure the length and pattern of apneic 
episodes, but also quantify the increase in the number and 
duration of such episodes as a response to narcotic adminis-
tration. This highlights the importance of respiratory moni-
toring in the post-operative environment where narcotics are 
frequently used to manage pain. RVM was able to quantify 
the adequacy of rescue breaths to maintain respiratory ho-
meostasis. The post-hoc analysis demonstrates the utility of 
the RVM in comprehensive respiratory analysis, which may 
augment or supplant polysomnography. Patient B, non-obese 
and with no previous diagnosis of OSA, had substantively 
more respiratory depression postoperatively than patient A, 
with known OSA.
The 2011 American Society of Anesthesiologists’ guide-
lines require monitoring of not just oxygenation, but also 
ventilation in the PACU. The quantitative measurements of 
MV and TV from the RVM can assist in decision making 
improve patient safety and optimize pain management in pa-
tients with or at risk for OSA. The RVM can be used with 
other measures for the assessment of ventilation in non-intu-
bated patients. Further studies to formalize the use of RVM 
for the detection and quantitation of apneas are on-going.
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